ved in replication of HCoV‐229E (Kono et al., 2008).

7.2  Lopinavir/ritonavir, leronlimab, galidesivir
Lopinavir/Ritonavir, commonly used for treatment of HIV infection, has been indicated for treatment of COVID‐19 in a number of reports (Kim et al., 2020). Previous studies suggested that when combined together, Lopinavir and Ritonavir act in con